Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.

Chartoff EH, Mavrikaki M.

Front Neurosci. 2015 Dec 16;9:466. doi: 10.3389/fnins.2015.00466. eCollection 2015. Review.

2.

Moderate voluntary exercise attenuates the metabolic syndrome in melanocortin-4 receptor-deficient rats showing central dopaminergic dysregulation.

Obici S, Magrisso IJ, Ghazarian AS, Shirazian A, Miller JR, Loyd CM, Begg DP, Krawczewski Carhuatanta KA, Haas MK, Davis JF, Woods SC, Sandoval DA, Seeley RJ, Goodyear LJ, Pothos EN, Mul JD.

Mol Metab. 2015 Jul 17;4(10):692-705. doi: 10.1016/j.molmet.2015.07.003. eCollection 2015 Oct.

3.

Probabilistic reward- and punishment-based learning in opioid addiction: Experimental and computational data.

Myers CE, Sheynin J, Balsdon T, Luzardo A, Beck KD, Hogarth L, Haber P, Moustafa AA.

Behav Brain Res. 2016 Jan 1;296:240-8. doi: 10.1016/j.bbr.2015.09.018. Epub 2015 Sep 14.

PMID:
26381438
4.

Effects of anabolic-androgens on brain reward function.

Mhillaj E, Morgese MG, Tucci P, Bove M, Schiavone S, Trabace L.

Front Neurosci. 2015 Aug 26;9:295. doi: 10.3389/fnins.2015.00295. eCollection 2015. Review.

5.

Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors.

Hipólito L, Wilson-Poe A, Campos-Jurado Y, Zhong E, Gonzalez-Romero J, Virag L, Whittington R, Comer SD, Carlton SM, Walker BM, Bruchas MR, Morón JA.

J Neurosci. 2015 Sep 2;35(35):12217-31. doi: 10.1523/JNEUROSCI.1053-15.2015.

PMID:
26338332
6.

Understanding opioid reward.

Fields HL, Margolis EB.

Trends Neurosci. 2015 Apr;38(4):217-25. doi: 10.1016/j.tins.2015.01.002. Epub 2015 Jan 29. Review.

PMID:
25637939
7.

Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.

Rorick-Kehn LM, Witcher JW, Lowe SL, Gonzales CR, Weller MA, Bell RL, Hart JC, Need AB, McKinzie JH, Statnick MA, Suico JG, McKinzie DL, Tauscher-Wisniewski S, Mitch CH, Stoltz RR, Wong CJ.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu036. doi: 10.1093/ijnp/pyu036.

8.

Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.

Crowley NA, Kash TL.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:51-60. doi: 10.1016/j.pnpbp.2015.01.001. Epub 2015 Jan 12.

PMID:
25592680
9.

Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.

Spagnolo PA, Ramchandani VA, Schwandt ML, Zhang L, Blaine SK, Usala JM, Diamond KA, Phillips MJ, George DT, Momenan R, Heilig M.

Alcohol Clin Exp Res. 2014 Dec;38(12):3024-32. doi: 10.1111/acer.12581.

10.

The kappa opioid receptor: from addiction to depression, and back.

Lalanne L, Ayranci G, Kieffer BL, Lutz PE.

Front Psychiatry. 2014 Dec 8;5:170. doi: 10.3389/fpsyt.2014.00170. eCollection 2014. Review.

11.

Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors.

Engle SE, McIntosh JM, Drenan RM.

Neuropharmacology. 2015 Apr;91:13-22. doi: 10.1016/j.neuropharm.2014.11.014. Epub 2014 Dec 4.

PMID:
25484253
12.

Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor.

Van Waes V, Ehrlich S, Beverley JA, Steiner H.

Neuropharmacology. 2015 Feb;89:77-86. doi: 10.1016/j.neuropharm.2014.08.024. Epub 2014 Sep 16.

13.

Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.

Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS.

Neuropharmacology. 2014 Nov;86:228-40. doi: 10.1016/j.neuropharm.2014.07.016. Epub 2014 Aug 10.

14.

The dopamine system and alcohol dependence.

Ma H, Zhu G.

Shanghai Arch Psychiatry. 2014 Apr;26(2):61-8. doi: 10.3969/j.issn.1002-0829.2014.02.002. Review. Erratum in: Shanghai Arch Psychiatry. 2014;26(3):156.

15.

Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.

Ehrich JM, Phillips PE, Chavkin C.

Neuropsychopharmacology. 2014 Dec;39(13):3036-48. doi: 10.1038/npp.2014.157. Epub 2014 Jun 27.

16.
17.

Psychiatric neural networks and neuropharmacology: Selected advances and novel implications.

Ghanemi A.

Saudi Pharm J. 2014 Apr;22(2):95-100. doi: 10.1016/j.jsps.2013.01.008. Epub 2013 Feb 10. Review.

18.

The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Klenowski P, Morgan M, Bartlett SE.

Br J Pharmacol. 2015 Jan;172(2):297-310. doi: 10.1111/bph.12618. Epub 2014 Jul 1. Review.

20.

Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.

Kivell BM, Ewald AW, Prisinzano TE.

Adv Pharmacol. 2014;69:481-511. doi: 10.1016/B978-0-12-420118-7.00012-3. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk